What's the matter with my platelet count falling even though I've been taking Ropremilast/Romigrastim?

Romiplostim/Romiplostim promotes the production of platelets by stimulating the thrombopoietic factor receptor (TPO-R), thereby increasing the number of platelets in patients with immune thrombocytopenia (ITP). However, although loprostim is effective for most patients, there are still a few patients who fail to see a significant increase in platelet count after treatment, or even experience a decrease in platelet count.

There may be several causes of low platelets. First, a patient's immune system may develop tolerance or resistance to the drug, resulting in a blunted platelet-producing response. Patients who use loproprima for a long time may gradually develop resistance to the drug, thus affecting the efficacy of the drug. An abnormal response of the immune system may result in inhibition of platelet production, resulting in a decrease in platelet levels.

In addition, the disease itself of some patients may be more complex and there may be other factors that affect platelet production. For example, patients may have other blood diseases, bone marrow dysfunction and other problems at the same time. These problems will affect the ability to produce platelets, resulting in the inability to effectively increase the number of platelets even with the use of roplastin. In some cases, insufficient drug dosage or long dosing intervals may also lead to unsatisfactory efficacy and a decrease in platelet count.

In addition, the side effects of loplastin may also affect platelet counts. Although the side effects of Roprostim are generally mild, in individual patients the drug may cause abnormalities in the bone marrow's production of other blood cells, which may also affect platelet production.

Therefore, during treatment, patients and doctors need to pay close attention to changes in platelet levels and conduct routine blood tests regularly. If the platelet count decreases, treatment may need to be adjusted, including changing medications, adjusting doses, or adding other auxiliary treatments. For some refractory patients, doctors may consider other treatments, such as immunosuppressants or different platelet production-boosting drugs.

Reference materials:https://en.wikipedia.org/wiki/Romiplostim